Carotid artery stent survey.
This article was originally published in The Gray Sheet
Data from 24 international interventional medical centers on 2,591 carotid artery stenting procedures show a technical success rate of about 98% and a 5% complication rate. The survey, conducted by Michael Wholey, MD, Louisiana State University, New Orleans, was presented March 2 at the annual meeting of the Society of Cardiovascular and Interventional Radiology in San Francisco. Results show a restenosis rate of 3% after six months and complication rates comparable to endarterectomy, the current standard of care for preventing stroke caused by carotid artery stenosis. Boston Scientific, Johnson & Johnson's Cordis, Guidant and Endotex are among companies developing products for use in carotid artery stenting...
You may also be interested in...
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.
C&D CEO Matthew Farrell says Zicam has 73% share in the US zinc-containing wellness product market. It's acquiring marketer Matrixx Initiatives at a price almost 15 times Zicam brand’s projected 2021 EBITDA.